The trial of Kurosu Pharma's executive board began on the first day of autumn, when the leaves in the mountains outside Namhae were just beginning to turn from green to gold and the harbor winds carried the first chill of the coming winter. The Namhae District Court had been retrofitted to accommodate the proceedings—additional benches had been brought in, a larger defendant's dock constructed, and a separate gallery established for the families of the victims, whose numbers had swelled to more than two hundred as the investigation had expanded. The media presence was unprecedented. Satellite trucks lined the streets around the courthouse, their antennas pointed skyward like mechanical sunflowers seeking an invisible sun, and the trial was being broadcast live to seventeen countries.
Judge Im Sang-ho presided from his elevated bench, his black robes crisp and his expression unreadable. The dead sparrow that had been left in his garden had been followed by other warnings—a threatening letter slipped under his door, an anonymous call to his wife's phone, a package containing a broken scale, the symbol of justice, its beam snapped in two. He had documented each threat and added them to the court record, and he had not recused himself. A judge who recused himself under pressure, he had told the Chief Justice, was a judge who had surrendered before the battle began.
The defendants occupied three rows of the courtroom, fifteen executives in total, each one dressed in the dark suits that had become the unofficial uniform of the Kurosu Pharma leadership. Their expressions ranged from defiant to resigned to carefully blank, but none of them looked at the families' gallery. None of them looked at the prosecution's table, where Min Soo-jin sat with her team of five assistant prosecutors and a mountain of documents that had taken six weeks to organize. And none of them looked at Lee Hiroshi, who sat alone in the center of the first row, his posture perfect, his hands folded on the table before him, his eyes fixed on Judge Im with the attentive respect of a student waiting for a lecture to begin.
The charges were read by the court clerk in a monotone that drained the words of their horror. Eighty-four counts of involuntary manslaughter for the Phase One and Phase Two deaths. Thirty-seven counts of premeditated murder for the Phase Three deaths at Harbor Light Hospice. Additional charges of fraud, conspiracy, obstruction of justice, and violations of the national medical ethics code. The reading took forty-five minutes, and when it was finished, the courtroom was silent.
"The defendants will enter their pleas," Judge Im said.
Fifteen defense attorneys rose, each one representing a different executive. Each one entered a plea of not guilty. The process took another thirty minutes, during which the families in the gallery sat in stony silence, their photographs of the dead held in their laps like shields.
When the pleas were complete, Prosecutor Min rose to deliver her opening statement. She had spent weeks preparing this speech, writing and rewriting it, testing phrases on her assistants and discarding anything that felt like rhetoric. She wanted the court to hear not her voice, but the voices of the dead. She wanted the executives in the defendant's dock to understand, perhaps for the first time, what they had done.
"Your Honor," she began, "the defendants in this case are not common criminals. They did not act out of greed, or anger, or desperation. They acted out of something far more dangerous—a belief that they had the right to decide whose life had value and whose life did not. They looked at the residents of Way of Peace Nursing Home, and Harbor Light Hospice, and Golden Years Residence, and they saw not people, but resources. Not human beings, but experimental subjects. Not lives to be protected, but costs to be managed."
She walked to the evidence table, where a single red capsule was displayed in a glass case. "This is Soma-X. It is a drug designed to treat vascular dementia. It is also a poison that causes the blood vessels to dissolve from the inside, leading to massive internal hemorrhaging and death. The defendants knew this. They knew it from the earliest trials, when the first subjects began to bleed from their gums and their eyes and their internal organs. And rather than stop the trials, rather than report the adverse effects, they did something that defies comprehension: they continued. They expanded. They moved the trials from facility to facility, from province to province, from country to country, always seeking populations that were more vulnerable, more isolated, less likely to be missed."
She paused, letting the silence stretch. "The defendants will argue that they were pursuing a cure for a terrible disease. They will argue that the deaths were unintended, that the subjects gave consent, that the benefits of the research outweighed its costs. These arguments are not merely false. They are an insult to the memory of every person who died."
She picked up a document from her table. "This is Protocol Zero, the internal manual that guided the Soma-X trials. It was written by the defendants themselves, and it reveals exactly what they believed. Section Two instructs administrators to obtain signatures from residents who are, quote, 'in a state of reduced cognitive capacity, such that the nature of the document being signed is not fully comprehended.' Section Three provides a list of approved phrases to use when notifying families of deaths, including 'passed peacefully in their sleep,' a phrase that was used to describe deaths that were anything but peaceful. And Clause Seven-Point-Four explicitly authorizes the forgery of consent forms. Forgery, Your Honor. Authorized by the same executives who now sit in this courtroom claiming they did nothing wrong."
She set the document down and turned to face the defendants directly. Her gaze swept across the rows of dark suits and blank faces until it settled on Lee Hiroshi, who met her eyes with an expression of polite interest, as though she were a graduate student presenting a paper at a conference he had agreed to attend.
"Lee Hiroshi, the CEO of Kurosu Pharma, will argue that he was unaware of the details of the Soma-X trials. He will claim that the decisions were made by subordinates, that the protocols were implemented without his knowledge, that he bears only symbolic responsibility for what happened. This is a lie. The evidence will show that Dr. Lee personally signed the authorization for Phase Two. The evidence will show that Dr. Lee personally reviewed the adverse event reports from Way of Peace. The evidence will show that Dr. Lee personally approved the expansion to Phase Three, even after eighty-four people had died. He knew. He approved. He is responsible."
A murmur ran through the courtroom. The journalists in the front rows scribbled furiously. The families in the gallery clutched their photographs tighter. And Lee Hiroshi's expression did not change. He continued to watch Min with the same attentive respect, as though she were an interesting puzzle that he had not yet solved.
The defense's opening statement was delivered by Lee's lead attorney, a man named Yun Chang-ho who had been recruited from the capital's most prestigious law firm and who was rumored to charge more per hour than most Namhae residents earned in a year. His voice was smooth and practiced, his arguments carefully calibrated to raise doubt without appearing to deny the obvious.
"The prosecution has told a compelling story," Yun began. "A story of villains and victims, of greed and suffering, of a corporation that placed profits above human lives. It is a story that appeals to our emotions, to our sense of justice, to our natural sympathy for the vulnerable and our natural anger at the powerful. But it is not the whole story. It is not even the true story."
He walked to the evidence table, his footsteps echoing on the polished floor. "Kurosu Pharma is not a villain in a melodrama. It is a company that employs twelve thousand people, that contributes billions to the national economy, that has developed treatments that have saved countless lives. The Soma-X program was an attempt to cure vascular dementia, a disease that affects millions of people worldwide. The scientists who worked on Soma-X believed they were pursuing a breakthrough that would transform medicine. They made mistakes. They cut corners. They caused suffering. But they did not murder anyone."
He turned to face the families' gallery, his expression carefully sympathetic. "The subjects of the Soma-X trials were elderly. They were sick. Many of them had advanced dementia and were approaching the end of their natural lives. The prosecution will ask you to believe that their deaths were murders, that every capsule of Soma-X was a bullet fired with intent to kill. But the truth is more complicated. The subjects died of complications from an experimental treatment—complications that the researchers did not fully understand, that they were trying to learn from, that they hoped to prevent in future trials. This is tragedy, yes. But it is not crime."
The families in the gallery began to murmur, their grief turning to anger. One woman stood up, a photograph of an elderly man clutched in her hands. "My father was not 'approaching the end of his natural life,'" she shouted. "He was healthy. He was strong. He walked three kilometers every morning until you people gave him your poison."
Judge Im banged his gavel. "The gallery will remain silent. Bailiffs, escort this woman out if necessary."
The woman sat down, but her eyes remained fixed on Yun Chang-ho with a fury that needed no words. The defense attorney waited for the commotion to subside, then continued as though nothing had happened.
"The defense will present expert testimony regarding the medical necessity of the Soma-X trials. We will show that the subjects were informed of the risks, to the extent that their conditions allowed. We will show that the researchers acted in good faith, believing that the potential benefits of the treatment justified its risks. And we will show that the deaths, while tragic, were not criminal. They were the unintended consequence of a sincere effort to advance medical science and save lives."
He returned to the defense table and sat down. The opening statements were complete. The trial had begun.
Min Soo-jin spent the afternoon presenting her first witnesses—Dr. Yoon with the toxicology reports, Sergeant Kang with the Harbor Light arson evidence, the orderlies who had found Go Myung-hwan's body. The testimony was methodical and devastating, each witness adding another layer to the mountain of evidence against Kurosu Pharma. But the real battle, Min knew, was still to come. The defense would present its case the following week, and Lee Hiroshi himself was scheduled to testify. The man who had played Bach for the dead would now have to speak for the living, and the outcome of the trial would depend on whether the court believed him.
As the session adjourned for the day, Hana caught Min's eye from the gallery. The prosecutor looked exhausted, her face drawn with the weight of the trial and the grief of her grandmother's revelation. But there was something else in her expression—a determination that had not been there before, a fire that had been kindled by the photograph in the manila envelope.
The trial would continue. The truth would continue to unfold. And somewhere outside the courthouse, the families of the dead were gathering for another vigil, their photographs held high, their voices raised in a chorus that the system could no longer ignore.
No comments yet. Be the first to comment!